SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-17-003701
Filing Date
2017-04-10
Accepted
2017-04-10 16:49:27
Documents
4
Period of Report
2017-04-10
Effectiveness Date
2017-04-10

Document Format Files

Seq Description Document Type Size
1 def14a.htm DEF 14A 502977
2 image_001.jpg GRAPHIC 101443
3 image_002.jpg GRAPHIC 67523
4 image_003.jpg GRAPHIC 66720
  Complete submission text file 0001493152-17-003701.txt   828993
Mailing Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 100 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37348 | Film No.: 17753970
SIC: 2834 Pharmaceutical Preparations